Related Experiment Video
Updated: Jun 24, 2026

LPS and ATP-induced Death of PMA-differentiated THP-1 Macrophages and its Validation
Published on: May 3, 2024
Programmed cell death and cancer
1Department of Obstetrics and Gynecology, West China Second Hospital, West China Center of Medical Sciences, Sichuan University, Chendu, Sichuan, China.
Abstract:
Programmed cell death (PCD) is an important terminal pathway for cells of multicellular organisms, and is involved in a variety of biological events that include morphogenesis, maintenance of tissue homeostasis, and elimination of harmful cells. Dysfunction of PCD leads to various diseases in humans, especially various cancers. Accumulating evidence indicates that PCD is closely related to anti-cancer therapy. Recently, many studies have subdivided PCD into the three categories: apoptosis, autophagy, and programmed necrosis, based on criteria such as morphological alterations, initiating death signal, and the activation of caspases. In this article, we will review the main features and functions of all three types of programmed cell death, focusing on their roles in tumour cells and the relationship of the three types of cell death in anti-cancer therapy.
Insights
Programmed cell death (PCD) encompasses apoptosis, autophagy, and programmed necrosis. Understanding these pathways is crucial for developing effective anti-cancer therapies by targeting cell death mechanisms in tumors.
Area of Science:
- Cell Biology
- Oncology
- Biochemistry
Background:
- Programmed cell death (PCD) is vital for multicellular organisms, regulating development and tissue health.
- Dysfunctional PCD is linked to human diseases, particularly various cancers.
- PCD plays a significant role in the efficacy of anti-cancer treatments.
Purpose of the Study:
- To review the main features and functions of the three primary types of PCD: apoptosis, autophagy, and programmed necrosis.
- To focus on the specific roles of these cell death modalities within tumor cells.
- To explore the interrelationships between these PCD types in the context of anti-cancer therapy.
Main Methods:
- Literature review of recent studies on programmed cell death.
- Analysis of criteria differentiating apoptosis, autophagy, and programmed necrosis (morphology, signaling, caspases).
- Synthesis of information regarding PCD's role in cancer and therapeutic strategies.
Main Results:
- PCD is classified into apoptosis, autophagy, and programmed necrosis based on distinct molecular and morphological characteristics.
- Each PCD type exhibits unique functions and influences tumor cell behavior differently.
- The interplay between these cell death pathways is critical for successful anti-cancer therapy.
Conclusions:
- Programmed cell death, encompassing apoptosis, autophagy, and programmed necrosis, is fundamental to biological processes and cancer development.
- Targeting specific PCD pathways offers promising avenues for novel anti-cancer therapeutic strategies.
- Further research into the complex interactions of these cell death types can optimize cancer treatment outcomes.
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Cellular Injury IlI: Cellular Death

